NVR vs NBIX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NVR · NVR Inc$6,298.29 ▼ 1.81%
NBIX · Neurocrine Biosciences$164.63 ▲ 3.05%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NVR -14.2%
- NBIX +9.7%
Head to head
| Metric | NVR | NBIX |
|---|---|---|
| Price | $6,298.29 | $164.63 |
| Change today | ▼ 1.81% | ▲ 3.05% |
| Market cap | $16.66B | $16.66B |
| Return, 3 months | +0.1% | -0.2% |
| Return, year to date | -13.6% | +16.1% |
| Return, 1 year | -13.1% | +8.0% |
| P/E (TTM) | 17.4 | 24.4 |
| P/B | 4.9 | 4.3 |
| P/E percentile vs own 5y | 87th | 12th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -7.9% | +39.5% |
| Net profit growth (YoY) | -27.5% | +34.3% |
| Gross margin | 21.5% | 97.9% |
| Operating margin | 14.2% | 23.9% |
| Net margin | 11.2% | 20.9% |
| Return on equity | 28.3% | 22.1% |
| Analyst target vs. price | +0.7% | +26.0% |
| Analyst buy share | 20% | 85% |
| RSI (14) | 56 | 69 |
| 30-day volatility | 39.4% | 45.5% |
| Max drawdown, 1 year | -31.3% | -27.2% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NVR is the largest of the group by market value.
- NBIX has returned the most over the past year.
- NVR carries the lowest trailing P/E.
- NBIX is growing revenue fastest.
- NBIX keeps the most profit per dollar of sales.
- NVR has been the calmest stock over the last 30 days.